No Detail Found!

Challenges and Progress in Related Development: A Review of Validation Protocols Substance Method

Author(s)
Koula Doukani Department of Biology, Faculty of Nature and Life Sciences, University of Ibn Khaldoun,Tiaret,Algeria
Md. Zamshed Alam Begh Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University,Dhaka 1207,Bangladesh
Abstract
The detection and quantification of related substances, including impurities and degradation products, are crucial for ensuring the quality and safety of pharmaceutical products. The development of robust analytical methods for related substances has faced numerous challenges, ranging from the complexity of pharmaceutical formulations to stringent regulatory requirements. This review highlights the key hurdles in related substance method development, including issues related to sensitivity, selectivity, and matrix effects, as well as the need for stability-indicating capabilities. It also examines the progress made in the field, particularly through the introduction of advanced chromatographic techniques such as UHPLC and SFC, and the coupling of mass spectrometry for enhanced sensitivity and specificity. The review further explores the role of automated method development and the adoption of standardized validation protocols guided by regulatory frameworks, alongside the application of Quality by Design (QbD) principles to optimize and ensure the robustness of analytical methods. Despite significant advancements, continuous monitoring, revalidation, and adaptation to emerging impurities remain critical for maintaining the reliability of these methods in pharmaceutical quality control.
Publication Details
Page(s) 790-800
Published Journal: International Journal of Membrane Science and Technology, Volume: 11, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
method development, pharmaceutical analysis, Mass Spectrometry, Impurities, Related Substances, Regulatory Guidelines, Validation Protocols, Substance, SFC, UHPLC, quality by design
References
Kommanaboyina B,Rhodes CT .1999 .Trends in stability testing, with emphasis on stability during distribution and storage. Drug Dev Ind Pharm, 25(7) : 857-68.
Lindholm J. Development .2004 .and validation of HPLC methods for analytical and preparative purposes. Acta Universitatis Upsaliensis, 13 : 1-23.
Blessy M,Patel RD,Prajapati PN,Agrawal YK .2014 .Development of forced degradation and stability indicating studies of drugs-A review. J Pharm Anal, 4(3) : 159-65.
Thiruvengadam D,Vasanth PM,Kumar P. A Stability-Indicating RP .2011 .HPLC Method for the Determination of Related Substances in Drug Substances and Drug Products. Chromatographia, 74 : 893-902.
Hu M,Tomita M,Hayashi T,Awazu S. .1998 .Simultaneous determination of related substances of irinotecan hydrochloride by reversed-phase ion-pair high-performance liquid chromatography. J Chromatogr A, 828(1-2) : 373-80.
ICH .2006 .Q3A (R2). Impurities in New Drug Substances. ICH Harmonized Tripartite Guideline, : .
Swartz ME,Krull IS .2012 .Analytical Method Development and Validation. , : .
Zambon S,Ellison SL,Williams A .2012 .Validation of a high-performance liquid chromatography method for related substances in a pharmaceutical drug substance. J Chromatogr A, 1257 : 181-9.
Chan CC,Lee YC,Lam H,Zhang XM .2004 .Analytical Method Validation and Instrument Performance Verification. , : .
Huynh-Ba K,Practices Best .2009 .. , : .
Kunimoto R,Harada M,Sugino T,Kuribayashi T. .2021 .Application of Quality by Design (QbD) to enhance the method robustness of bioanalytical LC-MS/MS assay for a peptide drug. Bioanalysis, 13(6) : 429-441.
Szczygiel M,Muchowicz A,Demkow U .2021 .Development of a novel LC-MS/MS method for quantifying low-concentration impurities. Pharm Anal Acta, 12(5) : 534-541.
Kellner R,Mermet JM,Otto M,Widmer HM .2017 .Analytical Chemistry: A Modern Approach to Analytical Science. , : .
Bliesner DM .2017 .Validating Chromatographic Methods: A Practical Guide. , : .
Chatfield K,Donohoe D,Shen M,Harris G .2020 .Process analytical technology (PAT) tools and applications in pharmaceutical manufacturing. Pharm Technol Eur, 32(3) : 40-45.
Molnár I. .2018 .Computer-assisted development and optimization in HPLC using quality by design (QbD) principles. Trends Analyt Chem, 105 : 405-415.
Snyder LR,Kirkland JJ,Dolan JW .2019 .Introduction to Modern Liquid Chromatography. , : .
McDowell MT,Metters JP,Banks CE .2016 .Simplifying complex bioanalytical procedures through automated sample preparation. Talanta, 160 : 312-322.
Shen H,Kim DH,Xia C .2019 .Heller A. A new approach for automated high throughput screening using microplate spectrophotometers. Anal Chem, 91(8) : 4528-4535.
Fechner P,Pirkowska A,Wierzba D .2018 .Effect of process parameters on analytical method validation for related substances. J Pharm Biomed Anal, 154 : 127-136.
Witte P,Nehrenheim E,Friedel M. .2020 .The role of chemometrics in optimizing the sensitivity of bioanalytical assays for related substances. J Chromatogr A, 1601 : 10-18.
.2005 .Q9 Quality Risk Management. , : .
Miller JN,Miller JC .2020 .Statistics and Chemometrics for Analytical Chemistry. , : .
Kennerley BJ,Lea P,Barton J .2020 .Identifying key challenges in the detection of trace impurities. Anal Bioanal Chem, 412(5) : 2033-2042.
Tallam AK,Alapati S,Nuli MV . .RP-HPLC method for analytical method development and validation of multi-kinase inhibitor. Journal of Integral Sciences. 2023 Feb, 25 : 20-6.
Musumarra G,Barresi A,Sapuppo D .2021 .Stability-indicating methods in drug impurity profiling: Developments and regulatory guidelines. J Pharm Sci, 110(6) : 2056-2065.
Wenk M,Cook G,Hilton K. .2019 .Innovations in SFC method development for pharmaceutical applications. Anal Chem, 91(14) : 8963-8972.
Swartz M,Krull I. .2021 .Advances in Supercritical Fluid Chromatography for Pharmaceutical Analysis. , : .
Berendsen HH,Smit AB .2019 .Practical applications of LC-MS/MS in drug discovery and development. J Chromatogr B, 1107 : 88-101.
Xie Y,Qian M,Wang T,Chen W. .2018 .Method validation for trace-level impurity quantification in pharmaceuticals using UHPLC-MS/MS. , 159 : 139-148.
Vamsi Mohana,Nuli Mohana . .Analytical quality by design (AQbD) based optimization of RPUPLC method for determination of Nivolumab and Relatlimab in bulk and pharmaceutical dosage forms. Future Journal of Pharmaceutical Sciences. 2024 Jul, 10(1) : .
Rao V,Ramkrishna R,Kumar D. .2020 .Emerging approaches to impurity profiling and their significance in drug regulation. Int J Pharm Sci Rev Res, 63(1) : 14-22.
Krauss M,Hollender J,Singer H .2019 .Coupling of chromatography to mass spectrometry for impurity identification. Anal Chim Acta, 1097 : 80-91.
.2003 .Q1A(R2) Stability Testing of New Drug Substances and Products. , : .
Lough WJ,Wainer IW .2016 .Drug Stereochemistry: Analytical Methods and Pharmacology. , : .
Kim D,Ruzevich P,Kim J .2019 .Comprehensive impurity profiling and structural elucidation in pharmaceutical compounds. Biomed Chromatogr, 33(5) : .
0

Citations

0

Downloads

69

Views